Medicare Part D does not allow plans to exclude drugs in six protected classes from their formularies, which may limit plans’ ability to negotiate rebates and lead to higher…
The Inflation Reduction Act (IRA) of 2022 is the most significant reform to US prescription drug pricing in two decades and the first expected to result in a net reduction in…
The United States spends substantially more on health care than most developed countries, yet leaves a greater share of the population uninsured. We argue that incremental…
